Search filters

Authors whose works are in public domain in at least one jurisdiction

List of works by Kristen K. Ciombor

A Comprehensive Review of Sequencing and Combination Strategies of Targeted Agents in Metastatic Colorectal Cancer

scientific article published on 11 October 2017

A modified regimen of biweekly gemcitabine and nab-paclitaxel in patients with metastatic pancreatic cancer is both tolerable and effective: a retrospective analysis

scientific article

A phase I trial investigating pulsatile erlotinib in combination with gemcitabine and oxaliplatin in advanced biliary tract cancers

scientific article

Abstract 335: Efficacy of FGFR inhibitors and combination therapies for acquired resistance in FGFR2-fusion cholangiocarcinoma

scholarly article

Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance).

scientific article published on 4 October 2017

Advances in the management of biliary tract cancers

scientific article published on January 1, 2013

Aflibercept

scientific article

Aflibercept--a decoy VEGF receptor

scientific article published on February 2014

All in the Levels- Programmed Death-Ligand 1 Expression as a Biomarker for Immune Checkpoint Inhibitor Response in Gastrointestinal Cancer Patients

scientific article published on 18 September 2020

Anal Carcinoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 July 2018

Clinical and molecular markers of immune checkpoint inhibitor (ICI) response in dMMR colorectal cancer (CRC) patients (pts).

scientific article published on 04 February 2020

Current Therapy and Future Directions in Biliary Tract Malignancies

scientific article published on September 1, 2013

Current evidence and controversies in the incorporation of biologics for metastatic colorectal cancer

scientific article published on 01 June 2014

Diagnosis and Diagnostic Imaging of Anal Canal Cancer

scientific article published on January 2017

Early detection of SARS-CoV-2 from staging PET-CT

scientific article published on 29 September 2020

Efficacy of FGFR Inhibitors and Combination Therapies for Acquired Resistance in FGFR2-Fusion Cholangiocarcinoma

scientific article published on 07 January 2020

Emerging treatments in recurrent and metastatic colorectal cancer.

scientific article published on September 2013

Evaluation of frozen tissue-derived prognostic gene expression signatures in FFPE colorectal cancer samples

scientific article

Evaluation of hepatic impairment on pharmacokinetics and safety of crizotinib in patients with advanced cancer

scientific article published on 21 February 2018

FGFR2 fusions and its effect of patient (pt) outcomes in intrahepatic cholangiocarcinoma (iCCA)

scholarly article

Genomic diversity of colorectal cancer: Changing landscape and emerging targets

scientific article

Highlights in Gastrointestinal (Colorectal) Cancer Treatment: The Primary Tumor Sidedness Debate and Advances in Immunotherapy

scientific article published on 29 September 2016

How Can Next-Generation Sequencing (Genomics) Help Us in Treating Colorectal Cancer?

scientific article

Hypermutated Tumors and Immune Checkpoint Inhibition

scientific article published on 19 January 2018

Immune-Related Adverse Events and Immune Checkpoint Inhibitor Efficacy in Patients with Gastrointestinal Cancer with Food and Drug Administration-Approved Indications for Immunotherapy

scientific article published on 14 January 2020

Immunological predictors of overall survival in treatment naïve metastatic pancreatic cancer patients.

scientific article published on 4 November 2015

Management of small cell lung cancer

scientific article published on 01 January 2006

Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade.

scientific article

Modified irinotecan and infusional 5-fluorouracil (mFOLFIRI) in patients with refractory advanced pancreas cancer (APC): a single-institution experience

scientific article published on 19 March 2016

NCCN Guidelines Insights: Colon Cancer, Version 2.2018

scientific article published on 01 April 2018

NCCN Guidelines Insights: Rectal Cancer, Version 6.2020

scientific article published on 01 July 2020

Nivolumab for previously treated unresectable metastatic anal cancer (NCI9673): a multicentre, single-arm, phase 2 study

scientific article published on 17 February 2017

Nuclear factor of activated T-cell activity is associated with metastatic capacity in colon cancer

scientific article published on 15 October 2014

Phase I Trial of Trametinib with Neoadjuvant Chemoradiation in Patients with Locally Advanced Rectal Cancer

scientific article published on 06 April 2020

Phase II Study of BGJ398 in Patients With FGFR-Altered Advanced Cholangiocarcinoma.

scientific article published on 28 November 2017

Phase II study of gemcitabine, oxaliplatin, and cetuximab in advanced pancreatic cancer

scientific article published on 01 October 2012

Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group

scientific article

Primary Tumor Sidedness as Prognostic and Predictive Biomarker in Metastatic Colorectal Cancer: Further Validation of a Potentially Practice-Changing Variable

scientific article published on 01 February 2017

Promising New Agents for Colorectal Cancer

scientific article published on 11 May 2018

Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma

scientific article published on 04 April 2016

Recent therapeutic advances in the treatment of colorectal cancer

scientific article

Rectal Cancer, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 July 2018

Rectothecal Fistula Secondary to a Tailgut Cyst With Malignant Transformation: An Abnormal Connection and Unusual Pathology

scientific article published on 18 December 2020

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study

scientific article published on 28 June 2019

Selumetinib for the treatment of cancer

scientific article published on 11 November 2014

Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 September 2019

Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer

scientific article published on 30 December 2015

Targeting metastatic colorectal cancer - present and emerging treatment options

scientific article

Transfusion medicine illustrated. Profound piperacillin-mediated drug-induced immune hemolysis in a patient with cystic fibrosis

scientific article published on 27 October 2011

Update on Anti-Angiogenesis Therapy in Colorectal Cancer

scientific article published on December 2015

Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?

scientific article